Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction

Nature Genetics

Volumn 21, Issue 2, 1999, Pages 182-186

  St John, Maie A R ^a   Tao, Wufan ^a   Fei, Xiaolan ^a   Fukumoto, Royd ^a   Carcangiu, Maria Luisa ^a   Brownstein, David G ^a   Parlow, Albert F ^b   McGrath, James ^a   Xu, Tian ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; DROSOPHILA MELANOGASTER; HYPOPHYSIS DISEASE; NONHUMAN; OVARY TUMOR; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SOFT TISSUE SARCOMA; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; OVARIAN NEOPLASMS; PITUITARY GLAND; PROTEIN KINASES; SARCOMA; SARCOMA, EXPERIMENTAL;

EID: 0032907439     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/5965     Document Type: Article

References (22)

1. Xu, T. et al. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development 121, 1053-1063 (1995).
2. Justice, R.W., Zilian, O., Woods, D.F., Noll, M. & Bryant, P.J. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 9, 534-546 (1995).
3. Tao, W. et al. Human homolog of the Drosophila Lats tumor suppressor modulates Cdc2 activity during mitosis. Nature Genet. 21, 177-181 (1999).
4. Nelson, J.F., Felicio, L.S., Randall, P.K., Sims, C. & Finch, C.B. A longitudinal study of estrous cyclicity in aging C57BL/6J mice. I. Cycle frequency, length, and vaginal cytology. Biol. Reprod. 27, 327-339 (1982).
5. kip1 mediate two seperate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev. 12, 2899-2911 (1998).
6. kip1-deficient mice. Cell 85, 733-744 (1996).
7. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707-720 (1996).
8. Williams, B.O. et al. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13, 4251-4259 (1994)
9. Jacks, T. et al. Effects of an Rb mutation in the mouse. Nature 359, 295-300 (1992).
10. Lee, S.L. et al. Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A. Science 273, 1219-1221 (1996).
11. Wheater, P.R., Burkitt, H.G. & Daniels, V.G. in Functional Histology (eds Wheater, P. & Burkitt H.G.) 290-291 (Churchill livinstone, New York, 1987).
12. Clement, P.B. Histology of the ovary. in Histology for Pathologists (ed. Sternberg, S.S.) 934-960 (Lippincott-Raven, Philadephia, 1997).
13. Serrano, M. et al. Role of the INK4a locus in tumor suppressor and cell mortality. Cell 85, 27-37 (1996).
14. DiGiovanni, J. Multistage carcinogenesis in mouse skin. Pharmacol. Ther. 54, 63-128 (1991).
15. Sigrist, S.J. & Lehner, C.F. Drosophila fizzy-related down-regulates mitotic cyclins and is required for cell proliferation arrest and entry into endocycles. Cell 90, 671-681 (1997).
16. Sprenger, F., Yakubovich, N. & O'Farrell, P.H. S-phase function of Drosophila cyclin A and its downregulation in G1 phase. Curr. Biol. 7, 488-499 (1997).
17. Thomas, B.J. et al. Roughex down-regulates G2 cyclins in G1. Genes Dev. 11, 1289-1298 (1997).
18. Hunter, T. & Pines, J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79, 573-582 (1994).
19. Kinzler, K.W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159-170 (1996).
20. Mansour, S.L., Thomas, K.R. & Capecchi, M.R. Disruption of the proto-oncogene int-2 in mouse embryo derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336, 348-352 (1988).
21. Capecchi, M.R. Altering the genome by homologous recombination. Science 244, 1288-1292 (1989).
22. Gossler, A., Doetschman, T., Korn, R., Serfling, E. & Kemler, R. Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc. Natl Acad. Sci. USA 83, 9065-9069 (1986).